Metropolitan Life Insurance Company (MetLife)’s Hudson Technologies HDSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,365
Closed -$26K 926
2024
Q1
$26K Hold
2,365
﹤0.01% 1732
2023
Q4
$31.9K Hold
2,365
﹤0.01% 1678
2023
Q3
$31.5K Hold
2,365
﹤0.01% 1655
2023
Q2
$22.8K Buy
2,365
+783
+49% +$6.81K ﹤0.01% 1864
2023
Q1
$13.8K Sell
1,582
-1,095
-41% -$10.6K ﹤0.01% 2043
2022
Q4
$27.1K Buy
2,677
+1,562
+140% +$15.3K ﹤0.01% 1841
2022
Q3
$8.2K Sell
1,115
-1,521
-58% -$12.8K ﹤0.01% 2294
2022
Q2
$19.8K Buy
+2,636
New +$21.7K ﹤0.01% 2057
2017
Q4
Sell
-26,833
Closed -$210K 2507
2017
Q3
$210K Sell
26,833
-148
-0.5% -$1.28K ﹤0.01% 2244
2017
Q2
$228K Buy
+26,981
New +$206K ﹤0.01% 2255

Other funds holding HDSN

Metropolitan Life Insurance Company (MetLife)'s HDSN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Hudson Technologies (HDSN) in Q2 2024, closing a stake of 2,365 shares — an estimated $26K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HDSN in Q2 2017 and held it in 10 quarters. The position peaked at $228K in Q2 2017. 160 funds tracked by Wall St. Rank hold HDSN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Hudson Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,365 Hudson Technologies shares in Q2 2024, an estimated $26K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Hudson Technologies in Q2 2017 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Hudson Technologies position peaked at $228K in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Hudson Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.